Research has shown NMN to decrease age-associated body weight gain, improve energy metabolism, insulin sensitivity and plasma lipid profile, enhanced eye function and other pathophysiologies
This remains an actively moving area, however: on February 27, 2026, the HHS Secretary publicly announced an intent to move roughly 14 of the 19 Category 2-listed peptides, reportedly including ipamorelin and CJC-1295, back toward Category 1 status, and multiple industry and legal-news outlets reported further FDA action in the following months easing Category 2-related restrictions on this group of peptides
Before GLP-1 agonists, most weight loss medications produced 5 to 10 percent body weight reduction at best
The biological shift starts around 35 with declining growth hormone, not when menopause arrives
Clinical Update 1/13/2025 Protein Powder Contamination Recent tests of protein powders by a separate group showed that certain forms of protein were more likely than others to be contaminated with lead and cadmium
